CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mycotopia Therapies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mycotopia Therapies Inc
100 SE 2nd St, Suite 2000
Phone: (954) 233-3511p:954 233-3511 MIAMI, FL  33131  United States Ticker: RMIIRMII
On May 5, 2023, Mycotopia Therapies Inc’s management concluded that its previously issued (i) audited balance sheet and cons; and (ii) unaudited interim financial statements for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30, 2022, should be restated. The company identified errors made in its previously issued financial statements for the periods ending December 31, 2021 and September 30, 2022. Management determined that these financial statements do not give effect to $288,000 cash compensation and the issuance of a warrant to purchase shares 5% of the fully diluted common stock outstanding of Mycotopia Therapies, Inc.
Business Summary
Mycotopia Therapies Inc is a United States-based company. The Company focuses on the use of psychedelics for the treatment of mental health issues. It intends to provide psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, posttraumatic stress disorder (PTSD), attention-deficit / hyperactivity disorder (ADHD), autism and addictions. Psychedelic therapy is a holistic and spiritual approach providing healing.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
8049 Offices and clinics of health practitioners, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Chief Financial Officer, Director BenKaplan 51 1/1/2022 1/20/2021
Director MarkCroskery 39 1/20/2021 1/20/2021

Subsidiaries
Business Name Address City State/Province Country
20/20 Produce Sales, Inc. 480 22nd Street Heyburn ID United States

Business Names
Business Name
20/20 Produce Sales, Inc.
RMII
RMIID
TPIA
TWGL

General Information
Outstanding Shares: 14,896,791 (As of 8/14/2024)
Shareholders: 112
Federal Tax Id: 870645794


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024